Should the UK trial faster routes for new medicines with the pharma industry?

The UK government and pharma industry have launched pilot schemes as part of implementing a UK-US pharma trade deal. The pilots will test new approaches to medicines pricing, access, adoption, productivity benefits, regional funding and industry co-investment in screening and care. Patient groups contributed to the joint taskforce developing the schemes.